ClinicalTrials.Veeva

Menu
V

Vantage Clinical Trials | Tampa, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Litifilimab
BIIB059
EVO756
Enpatoran

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials
Locations recently updated

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

The purpose of this global, multicenter, Phase 3 study is to evaluate the efficacy and safety of enpatoran over 24 weeks in participants with active...

Enrolling
Cutaneous Lupus Erythematosus
Systematic Lupus Erythematosus
Drug: Placebo
Drug: Enpatoran

This is a Phase III, randomized, double-blinded, Sham-controlled, multi-center study in subjects with single-level, symptomatic lumbar (L3- S1) inter...

Enrolling
Degenerative Disc Disease
Other: Sham (No Treatment)
Biological: IDCT (rebonuputemcel)

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic lupus erythematosus (SLE). T...

Active, not recruiting
Lupus Erythematosus, Systemic
Drug: Placebo
Drug: Litifilimab

This study will evaluate the efficacy and safety of EVO756 against placebo in adults with migraine.

Enrolling
Migraine
Drug: EVO756, Dose 1
Drug: Placebo

Trial sponsors

Biogen logo
C
D
E
Merck KGaA (EMD Serono) logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems